Andere Kunden interessierten sich auch für
![Enological Repercussions of Non-Saccharomyces Species 2.0]( "Enological Repercussions of Non-Saccharomyces Species 2.0")
Enological Repercussions of Non-Saccharomyces Species 2.066,99 €![Proteases-From Basic Structure to Function to Drug Design as Targeted Therapy]( "Proteases-From Basic Structure to Function to Drug Design as Targeted Therapy")
Proteases-From Basic Structure to Function to Drug Design as Targeted Therapy46,99 €![Practical Chemistry; Or, a Description of the Processes by Which the Various Articles of Chemical Research, in the Animal, Vegetable, and Mineral King]( "Practical Chemistry; Or, a Description of the Processes by Which the Various Articles of Chemical Research, in the Animal, Vegetable, and Mineral King")
Practical Chemistry; Or, a Description of the Processes by Which the Various Articles of Chemical Research, in the Animal, Vegetable, and Mineral King41,99 €![Co- And Post-Translational Modifications of Therapeutic Antibodies and Proteins]( "Co- And Post-Translational Modifications of Therapeutic Antibodies and Proteins")
Co- And Post-Translational Modifications of Therapeutic Antibodies and Proteins165,99 €![Advances in Manufacturing and Characterization of Functional Polyesters]( "Advances in Manufacturing and Characterization of Functional Polyesters")
Advances in Manufacturing and Characterization of Functional Polyesters89,99 €![Functional Biodegradable Nanocomposites]( "Functional Biodegradable Nanocomposites")
Functional Biodegradable Nanocomposites69,99 €![Polymers and Their Application in 3D Printing]( "Polymers and Their Application in 3D Printing")
Polymers and Their Application in 3D Printing72,99 €
Monoclonal antibodies (mAbs) are among the most specialised molecules for the recognition and capture of specific analytes. Hundreds of thousands of mAbs have been generated for a large number of different antigens with increasing affinity and specificity and are available for the most diverse purposes. Many of them have been validated as irreplaceable agents for diagnosis and therapy or as unique reagents for research. Others have been developed using emerging technologies that avoid the need for animal immunisation. This short book strives to gather the perspective view of the various contributing authors and to survey the new strategic assets adopted to generate novel monoclonal antibodies or surrogates, such as Fab, Fab2, ScFv and nanobodies, which have an increasing impact in biomedicine as therapeutic or diagnostic assets in various diseases.